RE: Trading18 Aug 2023 16:21
With the potential of significant news flow from the company and when you consider the constant news flow from the majors, latest $240 bill Novartis about to be spinning off Sandoz and concentrate on clever medicine such as Precision Oncology, well Avacta is soon to be the hottest company in town and be seriously re-rated.